Advisor Group Holdings, Inc. Capricor Therapeutics, Inc. Transaction History
Advisor Group Holdings, Inc.
- $40.6 Billion
- Q2 2024
A detailed history of Advisor Group Holdings, Inc. transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 162,300 shares of CAPR stock, worth $830,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162,300
Previous 158,200
2.59%
Holding current value
$830,976
Previous $1.07 Million
27.93%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding CAPR
# of Institutions
68Shares Held
6.33MCall Options Held
210KPut Options Held
374K-
Black Rock Inc. New York, NY1.63MShares$8.34 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$7.93 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA642KShares$3.28 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$2.46 Million0.0% of portfolio
-
State Street Corp Boston, MA401KShares$2.05 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $125M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...